go to main content
Research Radboudumc Technology Centers Radboud Biobank News Biobank Nijmegen Bladder Cancer Study (NBCS)
Listen
3 December 2019

The aim of NBCS is to investigate lifestyle factors and genetic factors in relation to the risk of bladder cancer, the course of the disease, and the effect of therapy. The influence of specific characteristics of the bladder tumor itself on the course and effect of therapy is also being studied. The ambition of NBCS is to be able to determine which people are at high risk of developing a bladder tumor and to be able to personalize the treatment of patients with a bladder tumor even better to the individual patient. NBCS consists of questionnaire data, additional information from medical files and existing national health registration systems (cancer registries, registries of death certificates and pathology archives) and biomaterial (DNA, whole blood and tumor tissue).

  • Want to know more about these subjects? Click on the buttons below for more news.

    Radboud biobank

Related news items

Farewell Dorine Swinkels

1 September 2026

On Friday, September 4th, 2026, Dorine Swinkels will retire as Professor of Experimental Clinical Chemistry at Radboudumc. She is also leaving the Radboud Biobank.

go to page

Greening Radboud Biobank – reduction number of aliquots in storage for future initiatives

1 September 2026

Like LUMC and NKI, the Radboud Biobank will also store fewer aliquots per collection tube.

go to page

Effect of Fit & Funding on external invoices

1 September 2026

The Radboud Biobank not only manages issuances and projects for Radboudumc but also provides external services. The Radboud Biobank invoices the external organization for these services.

go to page

New link between iLES and Castor EDC connects clinical data and biobank material

1 September 2026

The Biobank Information Management System, iLES, is now linked to Castor EDC. This development was realized within a KWF-funded project.

go to page

Radboud Biobank's 2025 annual report

3 March 2026

The Radboud Biobank's 2025 annual report is now available on request.

go to page

Aevai Health developed a virtual assistant

3 March 2026

Aevai Health has developed Alva - a virtual assistant to engage research participants, which can support participants with health literacy, understanding research protocols, and with using measurement devices.

go to page